Sunshine Biopharma, Inc.
USD0.06
+0.00 (+0.84%)
CEO
Steve N. Slilaty
IPO Date
2022-02-15
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Country
CA
Open
$0.08
Prev. Close
$0.06
Day Low
$0.06
Day High
$0.09
52W Low
$0.06
52W High
$0.24
Market Cap
$0.00B
Volume
0.00M
| 990,000 |
| $0.10 |
| 16 Feb 2021 | Slilaty Steve N. | director, officer: Chief Executive Officer | A-Award | Acquired | 20,000,000 | $0.00 |
| 16 Feb 2021 | Sebaaly Camille | director, officer: CFO/Secretary | A-Award | Acquired | 20,000,000 | $0.00 |
| 16 Feb 2021 | MERZOUKI ABDERRAZZAK | director, officer: Chief Operating Officer | A-Award | Acquired | 20,000,000 | $0.00 |
| 15 Jul 2020 | Sebaaly Camille | director, officer: CFO/Secretary | A-Award | Acquired | 1,300,000 | $0.00 |
| 15 Jul 2020 | Sebaaly Camille | director, officer: CFO/Secretary | A-Award | Acquired | 1,100,000 | $0.00 |
| 15 Jul 2020 | Sebaaly Camille | director, officer: CFO/Secretary | A-Award | Acquired | 550,000 | $0.00 |
| 15 Jul 2020 | Sebaaly Camille | director, officer: CFO/Secretary | A-Award | Disposed | 323,673 | $0.00 |
| 13 Jul 2020 | MERZOUKI ABDERRAZZAK | director, officer: Chief Operating Officer | A-Award | Acquired | 1,300,000 | $0.00 |